Lynparza for Breast Cancer

"Applicants to this clinical investigation must be between 18 and 99 years old, suffering from breast cancer. A total of 14 participants are being sought out for the trial."

"Unfortunately, this clinical trial is no longer admitting patients. Initially posted on July 23rd 2019 and last updated March 22nd 2022, its recruitment period has come to an end. If you are still seeking participation opportunities, there are currently 2923 trials for breast cancer treatment and 188 studies involving Lynparza that remain open."

"As per the specified inclusion criteria for this clinical study, prospective participants must be 18 years old or older and below 99."

"Lynparza is commonly used for curative treatment and advanced directives. It has also been known to provide relief from several other medical issues such as malignant neoplasm of ovary, primary peritoneal cancer, hallucinations, somatic disorders."

"Currently, Lynparza has 188 active clinical trials with 27 at Phase 3. Houston is the main location for these studies, but 9255 other sites are also participating in their assessment."

"Unfortunately, this medical trial is not presently recruiting any new patients. It was initially posted in the summer of 2019 and last updated on March 22nd 2022. If you are seeking a different clinical study to join, there are currently 2923 trials involving breast cancer that are actively enrolling participants as well as 188 studies concerning Lynparza which have open spots for enrolment."